BENZOYL PEROXIDE; CLINDAMYCIN PHOSPHATE | A207194 | ENCUBE ETHICALS PRIVATE LTD
| Case | Court | Filed | Status | Judge |
|---|---|---|---|---|
Dow Pharmaceutical Sciences, Inc. et al v. Tolmar, Inc. 2 patentsANDA 207194clindamycin phosphate and benzoyl peroxide | D. Del. | 2015-11-06 | Terminated 2016-05-23 | — |
Source: PACER. NOS 835 (Patent - Abbreviated New Drug Application).
Highest NADAC/Unit
$0.7668
per gm
Lowest NADAC/Unit
$0.7668
per gm
Brand NDCs
0
Generic NDCs
1
| NDC Description | NADAC/Unit | Unit | Type | Generic NADAC | Effective |
|---|---|---|---|---|---|
| 21922007440CLIND PH-BENZOYL PERO 1.2-2.5% | $0.7668 | GM | Generic | — | 2026-06-17 |
Source: NADAC (data.medicaid.gov). Prices reflect national average acquisition costs for retail community pharmacies.
No patent or exclusivity listings for this strength.